Semler Scientific Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 22, 2021 / 04:00PM GMT
Andrew Cooper - Raymond James Financial, Inc. - Analyst

Good morning or afternoon on the East Coast at this point, and welcome to day 2 of the Raymond James Human Health Innovation Conference. Thanks for joining us. I am Andrew Cooper. I cover diagnostics here for Raymond James.

And I'm excited to be joined by Semler Scientific for a presentation this morning. It's a company that has bring some unique capabilities and frankly a unique channel approach to testing for peripheral artery disease, which is dramatically underdiagnosed in the US. But I will leave it to the team to offer more details there.

Before I do turn it over, we will have some time at the end for Q&A, so please feel free to submit any questions. (Conference Instructions) With that, like I said, we are happy to be joined by the Semler team: CEO, Doug Murphy-Chutorian; and Chief Marketing Officer, Dennis Rosenberg. And I will hand it over to you guys to begin the presentation. Thanks.

Dennis Rosenberg - Semler Scientific, Inc. - CMO

Hello. This is Dennis Rosenberg, Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot